A Randomized, Double-blind, Placebo-controlled, Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
Latest Information Update: 22 Mar 2024
At a glance
- Drugs BWC 0977 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- Sponsors BUGWORKS Research
Most Recent Events
- 19 Mar 2024 Status changed from recruiting to discontinued.
- 31 Aug 2023 Planned End Date changed from 30 Nov 2024 to 30 Jul 2024.
- 31 Aug 2023 Planned primary completion date changed from 30 Aug 2024 to 30 Apr 2024.